Sanofi CEO showcases 12 blockbusters and increased R&D investment
TL;DR
Sanofi CEO Paul Hudson and company executives held an R&D day in Manhattan to address doubts about the company's ability to focus and execute, particularly in building a pipeline. Hudson touted 12 potential blockbusters and announced an increase in R&D spending, aiming to persuade skeptical investors.
- Sanofi R&D day: CEO Paul Hudson touts 12 blockbusters, ups R&D spend Endpoints News
- Sanofi says it has 12 blockbusters in its back pocket. Will investors believe it? STAT
- Sanofi CEO Defends Extra Spending, Ramping Up Revenue Forecast Bloomberg
- Sanofi: chief must prove he can win R&D game Financial Times
- Sanofi hails potential $1 billion-a-year drug candidates Reuters
Want the full story? Read the original reporting
Read on Endpoints News